SEC
Filing

SEC Filing Details

Document Details

Form
Filing Date
Mar 1, 2021
Document Date
Feb 25, 2021
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Altimmune
Issuer
ALTIMMUNE, INC.
Filer
Venrock Healthcare Capital Partners III, L.P.
 

Investor Contact

Richard Eisenstadt
Chief Financial Officer

Email: reisenstadt@altimmune.com

 

Email Alerts

Automatically receive Altimmune, Inc. financial information by e-mail

Subscribe